Related Experiment Videos
Diffuse alveolar hemorrhage after clopidogrel use
P K Kilaru1, M J Schweiger, H A Kozman
1Division of Cardiology, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01119, USA.
The Journal of Invasive Cardiology
|July 4, 2001
Summary
Pulmonary hemorrhage is a rare complication of coronary stent placement. This case highlights a potential link between clopidogrel and diffuse alveolar hemorrhage, a serious condition requiring clinical awareness.
Area of Science:
- Cardiology
- Pulmonology
- Pharmacology
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for treating coronary artery disease.
- Pulmonary hemorrhage is a rare but serious complication associated with certain antiplatelet agents used during PCI.
- Previous reports linked abciximab and tirofiban to this complication, but not clopidogrel.
Observation:
- A 56-year-old male patient underwent coronary stent placement.
- The patient received clopidogrel as part of his treatment regimen.
- Following clopidogrel administration, the patient developed diffuse alveolar hemorrhage.
Findings:
- This case presents the first reported instance of diffuse alveolar hemorrhage associated with clopidogrel use after PCI.
- The findings suggest a potential causal relationship between clopidogrel and pulmonary hemorrhage in this context.
- Diffuse alveolar hemorrhage is a life-threatening condition requiring prompt recognition and management.
Implications:
- Clinicians should maintain a high index of suspicion for pulmonary hemorrhage in patients receiving clopidogrel, especially post-PCI.
- Awareness of this rare complication is crucial for timely diagnosis and intervention.
- Further research may be warranted to elucidate the mechanism and incidence of clopidogrel-induced pulmonary hemorrhage.